Literature DB >> 30442666

Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function.

William McAlpine1, Lei Sun1, Kuan-Wen Wang1, Aijie Liu1, Ruchi Jain2, Miguel San Miguel2, Jianhui Wang1, Zhao Zhang1, Braden Hayse1, Sarah Grace McAlpine1, Jin Huk Choi1, Xue Zhong1, Sara Ludwig1, Jamie Russell1, Xiaoming Zhan1, Mihwa Choi1, Xiaohong Li1, Miao Tang1, Eva Marie Y Moresco1, Bruce Beutler3, Emre Turer3,2.   

Abstract

The SMCR8-WDR41-C9ORF72 complex is a regulator of autophagy and lysosomal function. Autoimmunity and inflammatory disease have been ascribed to loss-of-function mutations of Smcr8 or C9orf72 in mice. In humans, autoimmunity has been reported to precede amyotrophic lateral sclerosis caused by mutations of C9ORF72 However, the cellular and molecular mechanisms underlying autoimmunity and inflammation caused by C9ORF72 or SMCR8 deficiencies remain unknown. Here, we show that splenomegaly, lymphadenopathy, and activated circulating T cells observed in Smcr8 -/- mice were rescued by triple knockout of the endosomal Toll-like receptors (TLRs) TLR3, TLR7, and TLR9. Myeloid cells from Smcr8 -/- mice produced excessive inflammatory cytokines in response to endocytosed TLR3, TLR7, or TLR9 ligands administered in the growth medium and in response to TLR2 or TLR4 ligands internalized by phagocytosis. These defects likely stem from prolonged TLR signaling caused by accumulation of LysoTracker-positive vesicles and by delayed phagosome maturation, both of which were observed in Smcr8 -/- macrophages. Smcr8 -/- mice also showed elevated susceptibility to dextran sodium sulfate-induced colitis, which was not associated with increased TLR3, TLR7, or TLR9 signaling. Deficiency of WDR41 phenocopied loss of SMCR8. Our findings provide evidence that excessive endosomal TLR signaling resulting from prolonged ligand-receptor contact causes inflammatory disease in SMCR8-deficient mice.

Entities:  

Keywords:  Toll-like receptor; inflammation; inflammatory bowel disease; vesicle trafficking

Mesh:

Substances:

Year:  2018        PMID: 30442666      PMCID: PMC6298088          DOI: 10.1073/pnas.1814753115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  42 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap.

Authors:  Håvard Torvik Gotaas; Geir Olve Skeie; Nils Erik Gilhus
Journal:  Neuromuscul Disord       Date:  2016-03-28       Impact factor: 4.296

3.  Creatine maintains intestinal homeostasis and protects against colitis.

Authors:  Emre Turer; William McAlpine; Kuan-Wen Wang; Tianshi Lu; Xiaohong Li; Miao Tang; Xiaoming Zhan; Tao Wang; Xiaowei Zhan; Chun-Hui Bu; Anne R Murray; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

4.  Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production.

Authors:  Jin-Young Yang; Min-Soo Kim; Eugene Kim; Jae Hee Cheon; Yong-Soo Lee; Yeji Kim; Su-Hyun Lee; Sang-Uk Seo; Seung-Ho Shin; Sun Shim Choi; Bumseok Kim; Sun-Young Chang; Hyun-Jeong Ko; Jin-Woo Bae; Mi-Na Kweon
Journal:  Immunity       Date:  2016-04-12       Impact factor: 31.745

5.  Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?

Authors:  Silvia de Pasqua; Francesco Cavallieri; Roberto D'Angelo; Fabrizio Salvi; Nicola Fini; Roberto D'Alessandro; Rita Rinaldi; Antonio Fasano; Jessica Mandrioli
Journal:  Neurol Sci       Date:  2016-12-02       Impact factor: 3.307

6.  Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity.

Authors:  Yu You; Jian-Jiang Fu; Jun Meng; Guo-Dong Huang; Yu-Hui Liu
Journal:  Dig Dis Sci       Date:  2008-11-26       Impact factor: 3.199

7.  C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling.

Authors:  Joseph Amick; Agnes Roczniak-Ferguson; Shawn M Ferguson
Journal:  Mol Biol Cell       Date:  2016-08-24       Impact factor: 4.138

8.  IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis.

Authors:  B Li; R Alli; P Vogel; T L Geiger
Journal:  Mucosal Immunol       Date:  2013-12-04       Impact factor: 7.313

9.  C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice.

Authors:  Amanda Atanasio; Vilma Decman; Derek White; Meg Ramos; Burcin Ikiz; Hoi-Ching Lee; Chia-Jen Siao; Susannah Brydges; Elizabeth LaRosa; Yu Bai; Wen Fury; Patricia Burfeind; Ralica Zamfirova; Gregg Warshaw; Jamie Orengo; Adelekan Oyejide; Michael Fralish; Wojtek Auerbach; William Poueymirou; Jan Freudenberg; Guochun Gong; Brian Zambrowicz; David Valenzuela; George Yancopoulos; Andrew Murphy; Gavin Thurston; Ka-Man Venus Lai
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

10.  The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy.

Authors:  Christopher P Webster; Emma F Smith; Claudia S Bauer; Annekathrin Moller; Guillaume M Hautbergue; Laura Ferraiuolo; Monika A Myszczynska; Adrian Higginbottom; Matthew J Walsh; Alexander J Whitworth; Brian K Kaspar; Kathrin Meyer; Pamela J Shaw; Andrew J Grierson; Kurt J De Vos
Journal:  EMBO J       Date:  2016-06-22       Impact factor: 11.598

View more
  13 in total

1.  Receptor-like role for PQLC2 amino acid transporter in the lysosomal sensing of cationic amino acids.

Authors:  Gabriel Talaia; Joseph Amick; Shawn M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

Review 2.  Organellar homeostasis and innate immune sensing.

Authors:  Cassandra R Harapas; Elina Idiiatullina; Mahmoud Al-Azab; Katja Hrovat-Schaale; Thomas Reygaerts; Annemarie Steiner; Pawat Laohamonthonkul; Sophia Davidson; Chien-Hsiung Yu; Lee Booty; Seth L Masters
Journal:  Nat Rev Immunol       Date:  2022-02-23       Impact factor: 108.555

Review 3.  Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.

Authors:  Weilun Pang; Fenghua Hu
Journal:  J Neurochem       Date:  2020-12-18       Impact factor: 5.372

Review 4.  Below the surface: The inner lives of TLR4 and TLR9.

Authors:  Laura Marongiu; Laura Gornati; Irene Artuso; Ivan Zanoni; Francesca Granucci
Journal:  J Leukoc Biol       Date:  2019-03-22       Impact factor: 4.962

5.  PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation.

Authors:  Joseph Amick; Arun Kumar Tharkeshwar; Gabriel Talaia; Shawn M Ferguson
Journal:  J Cell Biol       Date:  2020-01-06       Impact factor: 10.539

6.  Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy.

Authors:  Christopher B Rodell; Maaz S Ahmed; Christopher S Garris; Mikael J Pittet; Ralph Weissleder
Journal:  Theranostics       Date:  2019-11-26       Impact factor: 11.556

7.  C9orf72-associated SMCR8 protein binds in the ubiquitin pathway and with proteins linked with neurological disease.

Authors:  John L Goodier; Alisha O Soares; Gavin C Pereira; Lauren R DeVine; Laura Sanchez; Robert N Cole; Jose Luis García-Pérez
Journal:  Acta Neuropathol Commun       Date:  2020-07-16       Impact factor: 7.801

Review 8.  C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?

Authors:  Elke Braems; Bart Swinnen; Ludo Van Den Bosch
Journal:  Acta Neuropathol       Date:  2020-09-02       Impact factor: 17.088

Review 9.  COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.

Authors:  Patrick C Bradshaw; William A Seeds; Alexandra C Miller; Vikrant R Mahajan; William M Curtis
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

10.  C9orf72 in myeloid cells suppresses STING-induced inflammation.

Authors:  Madelyn E McCauley; Jacqueline Gire O'Rourke; Alberto Yáñez; Janet L Markman; Ritchie Ho; Xinchen Wang; Shuang Chen; Deepti Lall; Mengyao Jin; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Viviana Valencia; Matthew Harms; Moshe Arditi; Caroline Jefferies; Robert H Baloh
Journal:  Nature       Date:  2020-08-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.